Share on StockTwits

Metlife (NYSE:MET)‘s stock had its “overweight” rating reaffirmed by JPMorgan Chase & Co. in a research note issued on Tuesday. They currently have a $63.00 target price on the stock, up from their previous target price of $58.00. JPMorgan Chase & Co.’s price target points to a potential upside of 13.39% from the stock’s previous close.

Metlife (NYSE:MET) traded up 1.71% during mid-day trading on Tuesday, hitting $56.51. 2,178,427 shares of the company’s stock traded hands. Metlife has a 1-year low of $45.52 and a 1-year high of $56.87. The stock’s 50-day moving average is $53.33 and its 200-day moving average is $52.09. The company has a market cap of $63.606 billion and a price-to-earnings ratio of 17.42.

Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $1.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.40 by $0.03. On average, analysts predict that Metlife will post $5.66 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on MET. Analysts at S&P Equity Research reiterated a “buy” rating on shares of Metlife in a research note on Wednesday, June 11th. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Metlife in a research note on Wednesday, June 11th. They now have a $57.00 price target on the stock. Finally, analysts at Barclays reiterated an “overweight” rating on shares of Metlife in a research note on Wednesday, June 11th. They now have a $65.00 price target on the stock, up previously from $62.00. Four analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $57.80.

MetLife, Inc (NYSE:MET) is a provider of insurance, annuities and employee benefit programs, serving 90 million customers in over 50 countries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.